Switch to:
More From Other Websites
Ultragenyx Downgraded At Morgan Stanley, Valuation 'Stretched' And Pipeline Faces Execution Risk Jul 27 2015
Synageva Biopharma Corp (GEVA) Acquisition Helps Baker Bros. Advisors Top All Others In Q2 Returns Jul 10 2015
SYNAGEVA BIOPHARMA CORP Files SEC form 8-K, Completion of Acquisition or Disposition of Assets,... Jun 23 2015
Alexion Completes Acquisition of Synageva Jun 23 2015
Alexion Accepts Shares of Synageva BioPharma Corp. Tendered Into Exchange Offer Jun 22 2015
GEVA helped advance Sectoral Asset 9.4% in May. ALXN did not Jun 17 2015
5 Healthy Stocks in the Top Biotech ETF - ETF News And Commentary Jun 17 2015
The Only Way to Play Biotech Buyouts Jun 09 2015
Synageva BioPharma Completes Targeted Enrollment in Phase 1/2 Trial with SBC-103 for... Jun 04 2015
SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces Investigation of The Board of Directors of... Jun 02 2015
Alexion and Synageva Announce Early Termination of Hart-Scott-Rodino Waiting Period for Alexion’s... May 29 2015
The Synageva BioPharma–Alexion Deal Spread Has Some Hair on It May 27 2015
Synageva BioPharma Files for Kanuma's Approval in Japan - Analyst Blog May 27 2015
Synageva BioPharma Submits Kanuma™ (Sebelipase Alfa) Application For LAL Deficiency In Japan May 26 2015
4 Big Biotech Companies to Sell Now May 26 2015
SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces Investigation of The Board of Directors of... May 22 2015
Pall-Danaher Transaction: What You Should Know about Danaher May 21 2015
Pall-Danaher Transaction: An Overview of Pall May 21 2015
Intercept's NASH Trial Design Irks Investors May 19 2015

Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GuruFocus Premium Plus Membership